Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production

Journal of Endocrinology

Volumn 190, Issue 2, 2006, Pages 515-525

  Coll, Anthony P ^d   Fassnacht, Martin ^a   Klammer, Steffen ^b   Hahner, Stephanie ^a   Schulte, Dominik M ^b   Piper, Sarah ^d   Tung, Y C Loraine ^d   Challis, Benjamin G ^d   Weinstein, Yacob ^c   Allolio, Bruno ^a   O'Rahilly, Stephen ^d   Beuschlein, Felix ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; PROOPIOMELANOCORTIN; TETRACOSACTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FEMALE; FOOD INTAKE; HORMONE SYNTHESIS; HYPERPHAGIA; IN VIVO STUDY; MITOGENESIS; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; STEROIDOGENESIS; UPREGULATION; WEIGHT REDUCTION; WILD TYPE; ZONA FASCICULATA;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BODY WEIGHT; CELL COUNT; CELL PROLIFERATION; EATING; FEMALE; IMMUNOBLOTTING; MICE; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; PRO-OPIOMELANOCORTIN;

EID: 33747888334     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06749     Document Type: Article

References (31)

1. Bennett HP, Seidah NG, Benjannet S, Solomon S & Chretien M 1986 Reinvestigation of the disulfide bridge arrangement in human pro-opiomelanocortin N-terminal segment (hNT 1-76). International Journal of Peptide Protein Research 27 306-313.
2. Bertagna X 1994 Proopiomelanocortin-derived peptides. Endocrinology and Metabolism Clinics of North America 23 467-485.
3. Beuschlein F, Looyenga BD, Bleasdale SE, Mutch C, Bavers DL, Parlow AF Nilson JH & Hammer GD 2003 Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice. Molecular and Cellular Biology 23(11) 3951-3964.
4. Beuschlein F, Shapiro I & Weinstein Y 2005 The adrenal X zone is involved in progesterone inactivation. Program of 87th Annual Meeting of the Endocrine Society. San Diego, CA, USA. Abstract P1-P333.
5. Bicknell AB, Lomthaisong K, Woods RJ, Hutchinson EG, Bennett HP, Gladwell RT & Lowry PJ 2001 Characterization of a serine protease that cleaves pro-gamma-melanotropin at the adrenal to stimulate growth. Cell 105 903-912.
6. Bradley RL, Mansfield JP & Maratos-Flier E 2005 Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes. Obesity Research 13 653-661.
7. Butler AA & Cone RD 2003 Knockout Studies defining different roles for melanocortin receptors in energy homeostasis. Annals of the New York Academy of Sciences 994 240-245.
8. Challis BG, Coll AP, Yeo GS, Pinnock SB, Dickson SL, Thresher RR, Dixon J, Zahn D, Rochford JJ, White A et al. 2004 Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36). PNAS 101 4695-4700.
9. Coll AP, Farooqi IS, Challis BG, Yeo GS & O'Rahilly S 2004a Proopiomelanocortin and energy balance: insights from human and murine genetics. Journal of Clinical Endocrinology and Metabolism 89 2557-2562.
10. Coll AP, Challis BG, Yen GS, Snell K, Piper SJ, Halsall D, Thresher RR & O'Rahilly S 2004b The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 145 4721-4727.
11. Coll AP, Challis BG, Lopez M, Piper S, Yeo GS & O'Rahilly S 2005 Proopiomelanocortin-deficient mice are hypersensitive to the adverse metabolic effects of glucocorticoids. Diabetes 54 2269-2276.
12. Cone RD 2005 Anatomy and regulation of the central melanocortin system. Nature Neuroscience 8 571-578.
13. De Souza J, Butler AA & Cone RD 2000 Disproportionate inhibition of feeding in A(y) mice by certain stressors: a cautionary note. Neuroendocrinology 72 126-132.
14. Denef C, Roudbaraki M & Van Bael A 2001 Growth and differentiation factors derived from the N-terminal domain of pro-opiomelanocortin. Clinical and Experimental Pharmacology and Physiology 28 239-243.
15. Estivariz FE, Hope J, McLean C & Lowry PJ 1980 Purification and characterization of a gamma-melanotropin precursor from frozen human pituitary glands. Biochemical Journal 191 125-132.
16. Estivariz FE, Iturriza F, McLean C, Hope J & Lowry PJ 1982 Stimulation of adrenal mitogenesis by N-terminal proopiocortin peptides. Nature 297 419-422.
17. Estivariz FE, Carino M, Lowry PJ & Jackson S 1988a Further evidence that N-terminal pro-opiomelanocortin pepticles are involved in adrenal mitogenesis. Journal of Endocrinology 116 201-206.
18. Estivariz FE, Morano ML Carino M, Jackson S & Lowry PJ 1988b Adrenal regeneration in the rat is mediated by mitogenic N-terminal pro-opiomelanocortin peptides generated by changes in precursor processing in the anterior pituitary. Journal of Endocrinology 116 207-216.
19. Fassnacht M, Hahner S, Hansen IA, Kreutzberger T, Zink M, Aderman K, Jakob F, Troppmair J & Allolio B 2003 N-terminal proopionnelanocortin acts as a mitogen in adrenocortical tumor cells and decreases adrenal steroidogenesis. Journal of Clinical Endocrinology and Metabolism 88 2171-2179.
20. Forbes S, Bui S, Robinson BR, Hochgeschwender U & Brennan MB 2001 Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. PNAS 98 4233-4237.
21. Hahner S, Fassnacht M, Hammer E Schammann M, Weismann D, Hansen IA & Allolio B 2005 Evidence against a role of human airway trypsin-like protease - the human analogue of the growth-promoting rat adrenal secretory protease-in adrenal tumourigenesis. European Journal of Endocrinology 152 143-153.
22. Hansen IA, Fassnacht M, Hahner S, Hammer F, Schammann M, Meyer SR, Bicknell AB & Allolio B 2004 The adrenal secretory serine protease AsP is a short secretory isoform of the transmembrane airway trypsin-like protease. Endocrinology 145 1898-1905.
23. Lowry PJ, Silas L, McLean C, Linton EA & Estivariz FE 1983 Pro-gamma-melanocyte-stimulating hormone cleavage in adrenal gland undergoing compensatory growth. Nature 306 70-73.
24. Lowry PJ, Estivariz FE, Silas L, Linton EA, McLean C & Crocombe K 1984 The case for pro-gamma-MSH as the adrenal growth factor. Endocrine Research 10 243-258.
25. McLean C, Hope J, Salacinski P, Estivariz F & Lowry PJ 1981 Purification and characterization of amino-terminal pro-opiocortin peptides from human pituitary glands. Bioscience Reports 1 843-849.
26. Raffin-Sanson ML, de Keyzer Y & Bertagna X 2003 Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. European Journal of Endocrinology 149 79-90.
27. Ramachandran J, Farmer SW Liles S & Li CH 1976 Comparison of the steroidogenic and melanotropic activities of corticotropin, alpha-melanotropin and analogs with their lipolytic activities in rat and rabbit adipocytes. Biochimica et Biophysica Acta 428 347-354.
28. Riccardi C, Bruscoli S & Migliorati G 2002 Molecular mechanisms of immunomodulatory activity of glucocorticoids. Pharmacological Research 45 361-368.
29. Richter WO & Schwandt P 1985 Physiologic concentrations of beta-lipotropin stimulate lipolysis in rabbit adipocytes. Metabolism 34 539-543.
30. Seger MA & Bennett HP 1986 Structure and bioactivity of the amino-terminal fragment of pro-opiomelanocortin. Journal of Steroid Biochemistry and Molecular Biology 25 703-710.
31. Smart JL, Tolle V & Low MJ 2006 Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice. Journal of Clinical Investigation 116 495-505.